[HTML][HTML] Vinpocetine attenuates ischemic stroke through inhibiting NLRP3 inflammasome expression in mice
D Han, J Wang, L Wen, M Sun, H Liu… - Journal of …, 2021 - journals.lww.com
Ischemic stroke is the leading cause of globe death and permanent disability, but its
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice
D Han, J Wang, L Wen, M Sun… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Ischemic stroke is the leading cause of globe death and permanent disability, but its
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice.
D Han, J Wang, L Wen, M Sun, H Liu… - Journal of Cardiovascular …, 2020 - europepmc.org
Ischemic stroke is the leading cause of globe death and permanent disability, but its
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
[HTML][HTML] Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice
D Han, J Wang, L Wen, M Sun, H Liu… - Journal of Cardiovascular …, 2021 - ncbi.nlm.nih.gov
Ischemic stroke is the leading cause of globe death and permanent disability, but its
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …
therapeutic strategies are limited. Over the past decades, multiprotein complexes called …